Next Article in Journal
Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
Next Article in Special Issue
Tetrandrine, a Compound Common in Chinese Traditional Medicine, Preferentially Kills Breast Cancer Tumor Initiating Cells (TICs) In Vitro
Previous Article in Journal
The Role of Tumour Stroma in Colorectal Cancer Invasion and Metastasis
Previous Article in Special Issue
Wnt/β-catenin Signaling in Normal and Cancer Stem Cells
Cancers 2011, 3(2), 2169-2175; doi:10.3390/cancers3022169
Review

X Inactivation and Progenitor Cancer Cells

Received: 11 February 2011; in revised form: 16 March 2011 / Accepted: 12 April 2011 / Published: 26 April 2011
(This article belongs to the Special Issue Cancer Stem Cells)
View Full-Text   |   Download PDF [133 KB, updated 27 April 2011; original version uploaded 26 April 2011]   |   Browse Figure
Abstract: In mammals, silencing of one of the two X chromosomes is necessary to achieve dosage compensation. The 17 kb non-coding RNA called Xist triggers X inactivation. Gene silencing by Xist can only be achieved in certain contexts such as in cells of the early embryo and in certain hematopoietic progenitors where silencing factors are present. Moreover, these epigenetic contexts are maintained in cancer progenitors in which SATB1 has been identified as a factor related to Xist-mediated chromosome silencing.
Keywords: X inactivation; Xist RNA; chromatin; cancer; epigenetics X inactivation; Xist RNA; chromatin; cancer; epigenetics
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Agrelo, R. X Inactivation and Progenitor Cancer Cells. Cancers 2011, 3, 2169-2175.

AMA Style

Agrelo R. X Inactivation and Progenitor Cancer Cells. Cancers. 2011; 3(2):2169-2175.

Chicago/Turabian Style

Agrelo, Ruben. 2011. "X Inactivation and Progenitor Cancer Cells." Cancers 3, no. 2: 2169-2175.


Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert